Navigation Links
Perceptive Informatics® Global Survey Results Indicate Wide Use of Industry-Standard Medical Imaging Metrics to Meet Study Milestones
Date:11/21/2011

ements resulting from recent and anticipated restructurings, including the anticipated additional restructuring charges of approximately $4 million in the second quarter of Fiscal Year 2012; the loss, modification, or delay of contracts which would, among other things, adversely impact the Company's recognition of revenue included in backlog; the Company's dependence on certain industries and clients; the Company's ability to win new business, manage growth and costs, and attract and retain employees; the Company's ability to complete additional acquisitions and to integrate newly acquired businesses or enter into new lines of business; the impact on the Company's business of government regulation of the drug,  medical device and biotechnology industry; consolidation within the pharmaceutical industry and competition within the biopharmaceutical services industry; the potential for significant liability to clients and third parties; the potential adverse impact of health care reform; and the effects of exchange rate fluctuations and other international economic, political, and other risks.
Such factors and others are discussed more fully in the section entitled "Risk Factors" of the Company's Quarterly Report on Form 10-Q for the quarter ended September 30, 2011 as filed with the SEC on November 9, 2011, which "Risk Factors" discussion is incorporated by reference in this press release.  The Company specifically disclaims any obligation to update these forward-looking statements in the future.  These forward-looking statements should not be relied upon as representing the Company's estimates or views as of any date subsequent to the date of this press release.

PAREXEL is a registered trademark of PAREXEL International Corporation, and Perceptive Informatics is a trademark of Perceptive Informatics, Inc. All other names or marks may be registered trademarks or trademarks of PAREXEL International Corporation, Perceptive Informatics, Inc. or th
'/>"/>

SOURCE PAREXEL International Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Perceptive Informatics Improves Clinical Trial Management With Enhanced TrialWorks(R) Solution
2. Perceptive Informatics Introduces Medical Imaging Methodology to Accelerate Development Decisions About Alzheimers Treatments
3. Perceptive Informatics Survey Results Reveal Top Barriers to Implementing Adaptive Trial Designs
4. Perceptive Informatics Enhances Investigator Application of New RECIST Version in Imaging-Based Oncology Trials
5. Perceptive Informatics Introduces Greater Convergence Between EDC and RTSM Solutions in Its eClinical Suite
6. Perceptive Informatics Integrates Medical Imaging Tracking with RTSM Technologies for Streamlined Workflow, Improved Data Quality
7. Perceptive Informatics® Global Survey Results Indicate Growing Demand for CTMS to Assist in More Efficient Site Monitoring and Management
8. Perceptive Informatics Brings More Efficiency to Clinical Development Process With SaaS-Based CTMS Solution
9. MacroGenics Begins Global Phase 2/3 Protege Study in Recent-onset Type 1 Diabetes Mellitus
10. Dr. Roger Kenneth Hershline PhD MD, CEO of Global Humanceuticals, Inc. Donates New HIV Drug
11. Directors Forum: PEPFAR and the Global AIDS Response
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/4/2015)... , August 4, 2015 ... report with market overview, trends, DRO analysis, market ... developments, competitive scenario and top competitor profiles in: ... Testing Market Development and Demand Forecast to ... , Explore full reports with detailed ...
(Date:8/4/2015)... 2015 Organovo Holdings, Inc. (NYSE MKT: ... delivering scientific and medical breakthroughs using 3D bioprinting ... Paul Gallant as its General Manager ... business. Mr. Gallant has more than 20 years of ... industry, most recently serving as chief operating officer ...
(Date:8/4/2015)... -- Research and Markets ( ... PharmaBiotech,s new report "Animal Biotechnology - Technologies, ... This report describes and evaluates animal biotechnology ... as well as improvement in food production. Knowledge ... of biotechnology to manage genetic disorders and improve ...
Breaking Medicine Technology:Global Drug of Abuse (DOA) Testing Market (Size of $2.9 Billion in 2014) to Witness 5% CAGR During 2015 - 2020 2Global Drug of Abuse (DOA) Testing Market (Size of $2.9 Billion in 2014) to Witness 5% CAGR During 2015 - 2020 3Global Drug of Abuse (DOA) Testing Market (Size of $2.9 Billion in 2014) to Witness 5% CAGR During 2015 - 2020 4Global Drug of Abuse (DOA) Testing Market (Size of $2.9 Billion in 2014) to Witness 5% CAGR During 2015 - 2020 5Organovo Holdings, Inc. Appoints Paul Gallant as General Manager 2Organovo Holdings, Inc. Appoints Paul Gallant as General Manager 3Animal Biotechnology 2014-2024 - 2015 Technologies, Markets and Companies Analysis 2Animal Biotechnology 2014-2024 - 2015 Technologies, Markets and Companies Analysis 3
... Corporation (NYSE: CFN ) today announced plans to release fourth quarter ... on the New York Stock Exchange. , , ... will host a webcast and conference call on Aug. 10 at 2 ... its fourth quarter and fiscal 2010, ended on June 30, 2010 . To access ...
... Mylan Inc. (Nasdaq: MYL ) today ... Senior Notes due 2020 at an issue price of 105.5% with a ... notes are being offered as additional notes under an existing indenture under ... Senior Notes due 2020 on May 19, 2010 . The notes ...
Cached Medicine Technology:CareFusion Will Host an Earnings Conference Call on Aug. 10 to Discuss the Results for the Fourth Quarter and Fiscal 2010 2Mylan Announces Pricing of Add-On Offering of Senior Notes 2Mylan Announces Pricing of Add-On Offering of Senior Notes 3
(Date:8/4/2015)... ... August 04, 2015 , ... The United Nations Foundation ... rights in Indonesia for a select group of U.S.-based journalists during the week ... and attend the International Conference on Family Planning in Bali. , In ...
(Date:8/4/2015)... (PRWEB) , ... August 04, 2015 , ... An ... found financial incentives to be a viable method for encouraging people to lose weight. ... on the future of their weight loss success, adding a financial incentive to the ...
(Date:8/4/2015)... Santa Barbara, CA (PRWEB) , ... August 04, ... ... if you are suffering from underarm sweat. Evolutions Medical & Day Spa in ... called miraDry, the only non-invasive, FDA cleared treatment that permanently eliminates sweat and ...
(Date:8/4/2015)... ... August 04, 2015 , ... Seedstock’s 4th ... Nov. 3 – 4, 2015, at UC San Diego, will explore innovations that ... food access, and manage resources efficiently against the dueling backdrop of a lingering ...
(Date:8/4/2015)... ... August 04, 2015 , ... Members receiving care from ... metrics – at a cost that is nine percent lower -- than those members ... Shield of New Jersey’s patient-centered programs. , “The promise of patient-centered, or value-based, ...
Breaking Medicine News(10 mins):Health News:UN Foundation Announces Press Fellowship to Indonesia with Focus on Women’s Health and Rights 2Health News:Article on Incentivizing Weight Loss Mirrors Similar Motivations Surrounding Weight Loss Surgery, Says Dr. Feiz & Associates 2Health News:Simple, Non-Invasive, Permanent Solution To Stop Underarm Sweating in Santa Barbara 2Health News:Simple, Non-Invasive, Permanent Solution To Stop Underarm Sweating in Santa Barbara 3Health News:Diversity of Urban and Hydroponic Farms of the Future to Highlight Seedstock Annual Conference Field Trip 2Health News:Diversity of Urban and Hydroponic Farms of the Future to Highlight Seedstock Annual Conference Field Trip 3Health News:Horizon BCBSNJ: 2014 Results Show Patient-Centered Care Continues to Deliver on Promise of Better Quality Care at a Lower Cost 2Health News:Horizon BCBSNJ: 2014 Results Show Patient-Centered Care Continues to Deliver on Promise of Better Quality Care at a Lower Cost 3
... statistics show that nearly 4,000 people in the UK die each year from ... ... -- On 24th November 1999, the Government,s ban on the use of ... people in the UK die each year from the effects of asbestos exposure ...
... The Committee for Human,Medicinal Products (CHMP) ... once-daily dosing of 800 mg PREZISTA(R) (darunavir) ... in treatment-naive adults (those who,have never taken ... was,developed by Tibotec Pharmaceuticals, and Tibotec, a ...
... acid content inhibits bacterial growth, experts say , , ... plenty of cranberry sauce on your plate this Thanksgiving, because ... according to the American Urological Association. , The high ... a home remedy for simple UTIs, help inhibit bacterial growth ...
... KONG, Nov. 27 /PRNewswire-Asia-FirstCall/ -- China,s leading,integrated medical ... ("Golden Meditech" or "the Company", Stock Code: 8180.HK) ... successfully brought in,Atlantis Investment Management Limited ("Atlantis Investment") ... new ordinary shares at a price,HK$1.03 per share. ...
... coincide with Staying Alive,s tenth,anniversary on World AIDS Day ... Travis McCoy, lead vocalist of the alternative,hip-hop band Gym ... Travis joins a ... Mary J Blige, Justin Timberlake and Diddy, who have ...
... Oregon wineries auction special Pinot Noirs to benefit healthcare services for ... this cause for 17 years, producers preview outstanding 2007 vintage. ... ... Patrons of Salud! The Oregon Pinot Noir Auction contributed generously to ...
Cached Medicine News:Health News:Nine Year Ban Fails to Eradicate Asbestos Related Diseases 2Health News:Nine Year Ban Fails to Eradicate Asbestos Related Diseases 3Health News:European Committee for Human Medicinal Products (CHMP) Issues Positive Opinion for Once-Daily PREZISTA(R) (Darunavir) as Part of Combination Therapy for Treatment-Naive Adults With HIV-1 2Health News:European Committee for Human Medicinal Products (CHMP) Issues Positive Opinion for Once-Daily PREZISTA(R) (Darunavir) as Part of Combination Therapy for Treatment-Naive Adults With HIV-1 3Health News:European Committee for Human Medicinal Products (CHMP) Issues Positive Opinion for Once-Daily PREZISTA(R) (Darunavir) as Part of Combination Therapy for Treatment-Naive Adults With HIV-1 4Health News:Cranberries May Help Prevent Urinary Tract Infections 2Health News:Golden Meditech Brings in Financial Investor Through New Share Issuance 2Health News:On Staying Alive's 10th Anniversary, Gym Class Heroes Singer Travis McCoy Named 2009 Foundation Ambassador 2Health News:On Staying Alive's 10th Anniversary, Gym Class Heroes Singer Travis McCoy Named 2009 Foundation Ambassador 3Health News:On Staying Alive's 10th Anniversary, Gym Class Heroes Singer Travis McCoy Named 2009 Foundation Ambassador 4Health News:On Staying Alive's 10th Anniversary, Gym Class Heroes Singer Travis McCoy Named 2009 Foundation Ambassador 5Health News:On Staying Alive's 10th Anniversary, Gym Class Heroes Singer Travis McCoy Named 2009 Foundation Ambassador 6Health News:Despite Economy, Oregon Wine Benefit !Salud! Raises Over $735,000 2Health News:Despite Economy, Oregon Wine Benefit !Salud! Raises Over $735,000 3
... test face is widely used for in or ... presents standard visual acuity from 20/15 to 20/200, ... cycles/degree) and a real-world driver's scene. , ,The ... it provides a standard acuity score, a functional ...
Contrast sensitivity testing, glare sensitivity testing and ETDRS acuity testing are provided in the self standardized CSV-1000 instrument. Patented photocell circuitry automatically monitors and cal...
... Cochrane Reviews enable all those involved with ... with the very latest evidence in their ... becomes harder each year as the volume ... problem by delivering the best single source ...
... enable all those involved with healthcare decisions ... very latest evidence in their field of ... each year as the volume of evidence ... delivering the best single source available for ...
Medicine Products: